The Francis Crick Institute
Browse
1-s2.0-S2589004222012688-main.pdf (4.39 MB)

Activity-based protein profiling of human and plasmodium serine hydrolases and interrogation of potential antimalarial targets.

Download (4.39 MB)
journal contribution
posted on 2022-09-20, 11:00 authored by Dara Davison, Steven Howell, Ambrosius P Snijders, Edgar Deu
Malaria remains a global health issue requiring the identification of novel therapeutic targets to combat drug resistance. Metabolic serine hydrolases are druggable enzymes playing essential roles in lipid metabolism. However, very few have been investigated in malaria-causing parasites. Here, we used fluorophosphonate broad-spectrum activity-based probes and quantitative chemical proteomics to annotate and profile the activity of more than half of predicted serine hydrolases in P. falciparum across the erythrocytic cycle. Using conditional genetics, we demonstrate that the activities of four serine hydrolases, previously annotated as essential (or important) in genetic screens, are actually dispensable for parasite replication. Of importance, we also identified eight human serine hydrolases that are specifically activated at different developmental stages. Chemical inhibition of two of them blocks parasite replication. This strongly suggests that parasites co-opt the activity of host enzymes and that this opens a new drug development strategy against which the parasites are less likely to develop resistance.

Funding

Crick (Grant ID: CC1063, Grant title: STP Proteomics) Wellcome Trust (Grant ID: 099950/B/12/Z, Grant title: WT 099950/B/12/Z) Crick (Grant ID: 10043, Grant title: Blackman FC001043)

History